Inception Cohort Registry Study of Patients with Crohn's disease

Not Applicable

Recruiting

• Conditions: Crohn' s disease(CD)

• Registration Number: JPRN-UMIN000032237
• Lead Sponsor: Janssen Pharma K.K.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-04-13
• Last Update Posted: 17 October 2023
• Study Completion: 2024-06-30

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 900

Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients who have used a biological drug having an indication for auto-immune diseases before diagnosis of CD 2.Patients with unknown dates (month and year) of CD diagnosis. 3.Patients currently enrolled or expected to be enrolled in other registration trial(s) at the registry entry.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of proportion(%)of patients using each CD treatment after CD diagnosis.

Secondary Outcome Measures

Name	Time	Method
1.Time to start using a biological drug from CD diagnosis 2.Duration of each CD treatment, Time to next CD treatment 3.Time to CD-related surgery from CD diagnosis 4.Change in HBI score in 4 years 5.Change in QOL indices (FACIT-Fatigue, short inflammatory bowel disease questionnaire[SIBDQ], and work productivity and activity impairment questionnaire: General Health[WPAI:GH])in 4 years. 6.Adverse events in each drug therapy for CD